VIE/EUZG (VIE/EUZG)

Vienna Stock Exchange: VIE/EUZG · EUR

€13.3

-0.24 (-1.8%)· Recorded snapshot

Market cap	827.3M
Revenue (ttm)	312.5M
Net income (ttm)	49.7M
EPS (ttm)	€0.79
P/E (trailing)	16.7x
P/E (forward)	15.9x
Dividend	€0.22 (1.66%)

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Revenue (ttm): 312.5M
Net income (ttm): 49.7M
EPS (ttm): €0.79
P/E (trailing): 16.7x
P/E (forward): 15.9x
Market cap: 827.3M

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

Refreshed 2026-10-30 13:30 UTC

Forward P/E15.9

P25 14.3P50 18.7P75 25.4

Trailing P/E16.7

P25 20.4P50 26.7P75 39.7

ROE20.1

P25 4.8P50 10.6P75 20.1

ROIC26.5

P25 5.8P50 9.5P75 18.2

Benchmarks · 1M

All VIE/EUZG indicators

Market & fundamental data

Available fields

228

Groups with data

Currency

EUR

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Amount currency	EUR
Country	Germany
Country code	AT
Earnings date	2026-11-12
Employees	1,105
Employees change	7
Employees growth	0.64%
Enterprise value	EUR 759.3M
Exchange	Vienna Stock Exchange
Financial currency	EUR
Financial report date	2026-06-30
First seen	2026-05-10
Fiscal year end	December
Founded	1992
Industry	Medical Devices
Is primary listing	No
ISIN number	DE0005659700
Last earnings date	2026-08-13
Last refreshed	2026-10-30
Last stock split date	2025-08-13
Last stock split type	Forward
Market cap	EUR 827.3M
Next earnings date	2026-11-12
Price	EUR 13.27
Price currency	EUR
Sector	Healthcare
SIC code	2810
Stock price date	2026-10-29
Symbol	vie/EUZG
Website	https://www.ezag.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Average P/E ratio (10Y)	29.61x
Average P/E ratio (3Y)	27.4x
Average P/E ratio (5Y)	32.43x
Earnings yield	5.99%
EV/Earnings	15.27x
EV/EBIT	10.04x
EV/EBITDA	8.19x
EV/FCF	32.02x
EV/Sales	2.43x
FCF / EV yield	3.12%
FCF yield	2.87%
Forward P/E	15.85x
Graham number	8.82758
Graham upside	-33.48%
Lynch fair value	EUR 8.05
Lynch upside	-39.35%
P/B ratio	3.06x
P/E ratio	16.7x
P/FCF ratio	34.88x
P/OCF ratio	16.8x
P/S ratio	2.65x
Price / tangible book value	3.73x
Price/EBITDA ratio	9.33x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT margin	24.07%
EBITDA margin	28.37%
Effective tax rate	31.34%
FCF margin	7.59%
Gross margin	48.72%
Operating margin	24.07%
Pretax margin	23.31%
Profit margin	15.92%
Profit per employee	EUR 45,009
Profitable quarters	70
Profitable years	19
Revenue per employee	EUR 282,806
ROA	10.3%
ROA (5Y)	8.24%
ROCE	18.7%
ROE	20.14%
ROE (5Y)	17.72%
ROIC	26.46%
ROIC (5Y)	23.8%
Tax / revenue	7.31%

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
EPS growth	36.42%
EPS growth (Q)	1.55%
EPS growth (QoQ)	14.63%
EPS growth 10Y	20.03%
EPS growth 3Y	24.41%
EPS growth 5Y	10.02%
EPS growth quarters	4
EPS growth years	2
FCF growth	-58.15%
FCF growth (Q)	-64.41%
FCF growth 3Y	3.92%
FCF growth 5Y	-7.32%
Gross profit growth	4.7%
Gross profit growth (Q)	-6.78%
Gross profit growth 3Y	11.89%
Gross profit growth 5Y	10.19%
Net income growth	35.73%
Net income growth (Q)	2.48%
Net income growth (QoQ)	15.66%
Net income growth 3Y	24.55%
Net income growth 5Y	10.09%
Net income growth quarters	7
Net income growth years	2
OCF growth	-34.21%
OCF growth (Q)	-49.19%
OCF growth (QoQ)	47.59%
OCF growth 10Y	14.1%
OCF growth 3Y	3.78%
OCF growth 5Y	3.65%
Operating income growth	8.11%
Operating income growth (Q)	-6.28%
Operating income growth 3Y	17.24%
Operating income growth 5Y	11.59%
Revenue growth	4.42%
Revenue growth (Q)	-5.22%
Revenue growth (QoQ)	4.73%
Revenue growth 10Y	9.01%
Revenue growth 3Y	10.31%
Revenue growth 5Y	11.42%
Revenue growth years	5

Financial statements

Income-statement and cash-flow amounts, totals and per share.

Metric	Value
Capital expenditures	EUR -25.5M
Depreciation and amortization	EUR 13.4M
EBIT	EUR 75.2M
EBITDA	EUR 88.7M
EPS	EUR 0.79
Financing cash flow	EUR -23M
Free cash flow	EUR 23.7M
Gross profit	EUR 152.2M
Income taxes	EUR 22.8M
Investing cash flow	EUR -29.4M
Net borrowing	EUR -10.7M
Net cash flow	EUR -2.1M
Net income	EUR 49.7M
Operating income	EUR 75.2M
Revenue	EUR 312.5M

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Altman Z-Score	5.21
Book value per share	EUR 4.30
Debt / EBITDA	0.44
Debt / equity	0.15
Debt / FCF	1.73
Goodwill	EUR 35.6M
Interest coverage	16.33
Long-term assets	EUR 223.8M
Long-term liabilities	EUR 131.6M
Net cash (debt)	EUR 69.3M
Net cash / market cap	8.38%
Net cash growth	8.6%
Net debt / EBITDA	-0.78
Net debt / equity	-0.26
Net debt / FCF	-2.92
Piotroski F-Score	7
Property, plant and equipment	EUR 140.8M
Shareholders' equity	EUR 270.6M
Tangible book value	EUR 221.8M
Tangible book value per share	EUR 3.55
Total assets	EUR 474.2M
Total cash	EUR 110.3M
Total debt	EUR 41M
Total liabilities	EUR 203.5M

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Asset turnover	0.68
Current assets	EUR 250.4M
Current liabilities	EUR 71.9M
Current ratio	3.48
Inventory turnover	3.34
Net working capital	EUR 77.8M
Quick ratio	2.65
Working capital	EUR 178.4M
Working capital turnover	1.87

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback yield / dilution	-0.18%
Dividend growth	0%
Dividend growth years	0
Dividend payment date	2026-06-29
Dividend payment years	2
Dividend payout frequency	Annual
Dividend per share	EUR 0.22
Dividend yield	1.66%
Ex-dividend date	2026-06-25
Last dividend	EUR 0.22
Payout ratio	27.68%
Shareholder yield	1.48%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
150-day SMA	EUR 14.15
1D price change	-1.78%
1M price change	5.74%
1M total return	5.74%
1W price change	-0.52%
1W total return	-0.52%
1Y price change	-21.99%
1Y return CAGR	-20.89%
1Y total return	-20.87%
20-day SMA	EUR 12.69
200-day SMA	EUR 14.36
3M price change	-1.19%
3M total return	-1.19%
50-day SMA	EUR 12.69
50-day SMA vs 200-day SMA	50under200
52-week high	EUR 17.38
52-week high date	2025-11-13
52-week low	EUR 12.06
52-week low date	2026-10-07
6M price change	-11.83%
6M total return	-10.57%
All-time high	EUR 23.02
All-time high date	2025-07-17
All-time low	EUR 12.06
All-time low date	2026-10-07
Average true range (ATR)	EUR 0.25
Average volume	10
Change from 52-week high	-23.65%
Change from 52-week low	10.03%
Change from all-time high	-42.35%
Change from all-time low	10.03%
Change from open	0.45%
Day's gap	-2.22%
High price	EUR 13.36
Low price	EUR 13.21
Monthly RSI	41.08
Open price	EUR 13.21
Position in 52-week range	40%
Previous close	EUR 13.51
Price vs 150-day SMA	-6.19%
Price vs 20-day SMA	4.54%
Price vs 200-day SMA	-7.59%
Price vs 50-day SMA	4.55%
Relative volume	20
RSI	60.13
Sharpe ratio	-0.73
Sortino ratio	-0.91
Weekly RSI	45.55
YTD price change	-13.04%
YTD total return	-11.8%

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	42.8M
Shares change (QoQ)	0.19%
Shares change (YoY)	0.18%
Shares held by insiders	0%
Shares held by institutions	20.95%

Deeper analysis on VIE/EUZG

14 sections in the full report · jump straight to what you need

Forecast

Base and Bull forecast paths with report-date return framing.

→

Valuation

Fair-value bridge, DCF, owner earnings, and peer multiples.

→

Sensitivity

Cost-of-equity and terminal-growth stress table.

→

Risks

Kill scenarios, soft-pass flags, and downside catalysts.

→

Earnings

Next earnings setup and beat / inline / miss thresholds.

→

Position sizing

Entry, exit, conviction, and quarterly monitoring rules.

→

Financials

Revenue, margins, cash flow, and balance-sheet context.

→

Peers

Relative valuation and profitability against the cohort.

→

Moat

Economic-profit evidence and competitive advantage risk.

→

Industry cycle

Sector phase, capital cycle, and secular tailwinds.

→

Frequently asked questions

About this VIE/EUZG report

Is a complete VIE/EUZG research report available?

No complete published report is available for vie/EUZG (VIE/EUZG) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

VIE/EUZG (VIE/EUZG)

Price

Financial snapshot

Fair-value bridge

Latest news · VIE/EUZG

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All VIE/EUZG indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on VIE/EUZG

Frequently asked questions